Magar, S. D., and P. Y. Pawar. “In Silico ADMET Screening & Molecular Docking of Some 1-(5-(4-Chlorophenyl)-1,3,4-Oxadiazol-3(2H)-Yl) Ethanone Derivatives to Be Developed As Triple Mutant T790M/C797S EGFR Inhibitors”. International Journal of Health Sciences, vol. 6, no. S3, June 2022, pp. 10432-51, doi:10.53730/ijhs.v6nS3.9448.